Literature DB >> 30784008

Intraoperative reduction of vasopressors using processed electroencephalographic monitoring in patients undergoing elective cardiac surgery: a randomized clinical trial.

C Sponholz1, C Schuwirth2, L Koenig2, H Hoyer3, S M Coldewey2,4, C Schelenz2, T Doenst5, A Kortgen2, M Bauer2.   

Abstract

Intraoperative vasopressor and fluid application are common strategies against hypotension. Use of processed electroencephalographic monitoring (pEEG) may reduce vasopressor application, a known risk factor for organ dysfunction, in elective cardiac surgery patients. Randomized single-centre clinical trial at Jena University Hospital. Adult patients operated on cardiopulmonary bypass or off-pump coronary artery bypass grafting were randomised to receive anesthesia with visible or blinded pEEG using Narcotrend™. In blinded-Narcotrend (NT) depth of anesthesia was extrapolated from clinical signs, hemodynamic response and anesthetic concentration, supplemented by target indices between 37 and 64 in the visible-NT group. Intraoperative norepinephrine requirement (primary endpoint), fluid balance, extubation time, delirium occurrence and adverse events were evaluated. Patients of the intent-to-treat population (visible-NT: n = 123, blinded-NT: n = 122) had similar patient and procedural characteristics. Adjusted for type of surgery intraoperative Norepinephrine application was significantly reduced in visible-NT (n = 120, robust mean of cumulative dose 4.71 µg/kg bodyweight) compared to blinded-NT patients (n = 119, 6.14 µg/kg bodyweight) (adjusted robust mean difference 1.71 (95% CI 0.33-3.10) µg/kg bodyweight). Although reduction in patients operated on cardiopulmonary bypass was higher the interaction was not significant in post-hoc subgroup analysis. Intraoperative fluid balance was similar among both groups and strata. Extubation time was non-significantly lower in visible than in blinded-NT group. Overall postoperative delirium risk was 16.4% without differences among the groups. Adverse events-sudden movement/coughing, perspiration or hypertension-occurred more often with visible-NT, while one blinded-NT patient experienced intraoperative awareness. Titration of depth of anesthesia in elective cardiac surgery patients using pEEG allows to reduce application of norepinephrine.

Entities:  

Keywords:  Adverse events; Cardiac anesthesia; Catecholamines; Neuromonitoring

Mesh:

Substances:

Year:  2019        PMID: 30784008     DOI: 10.1007/s10877-019-00284-1

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  34 in total

1.  Limitation in monitoring depth of anesthesia: a case report.

Authors:  Marco Cascella; Francesca Bifulco; Daniela Viscardi; Maura C Tracey; Domenico Carbone; Arturo Cuomo
Journal:  J Anesth       Date:  2015-12-15       Impact factor: 2.078

2.  Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting.

Authors:  V Tomic; S Russwurm; E Möller; R A Claus; M Blaess; F Brunkhorst; M Bruegel; K Bode; F Bloos; J Wippermann; T Wahlers; H-P Deigner; J Thiery; K Reinhart; M Bauer
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

Review 3.  The Narcotrend monitor.

Authors:  S Kreuer; W Wilhelm
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2006-03

4.  Association between vasopressor dependence and early outcome in patients after cardiac surgery.

Authors:  F Weis; E Kilger; A Beiras-Fernandez; K Nassau; D Reuter; A Goetz; P Lamm; L Reindl; J Briegel
Journal:  Anaesthesia       Date:  2006-10       Impact factor: 6.955

Review 5.  Practical use of the raw electroencephalogram waveform during general anesthesia: the art and science.

Authors:  Cambell Bennett; Logan J Voss; John P M Barnard; James W Sleigh
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

Review 6.  Perioperative hypotension and myocardial ischemia: diagnostic and therapeutic approaches.

Authors:  Amrik Singh; Joseph F Antognini
Journal:  Ann Card Anaesth       Date:  2011 May-Aug

Review 7.  The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care.

Authors:  Z Hajat; N Ahmad; J Andrzejowski
Journal:  Anaesthesia       Date:  2017-01       Impact factor: 6.955

8.  Bispectral index and electroencephalographic entropy in patients undergoing aortocoronary bypass grafting.

Authors:  A Lehmann; M Schmidt; C Zeitler; A-H Kiessling; F Isgro; J Boldt
Journal:  Eur J Anaesthesiol       Date:  2007-01-23       Impact factor: 4.330

9.  Facial nerve electromyographic monitoring to predict movement in patients titrated to a standard anesthetic depth.

Authors:  W Scott Jellish; John P Leonetti; Carl M Buoy; James M Sincacore; Kristina J Sawicki; Micheal P Macken
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

10.  Craniofacial electromyogram activation response: another indicator of anesthetic depth.

Authors:  R C Dutton; W D Smith; H L Bennett; S Archer; N T Smith
Journal:  J Clin Monit Comput       Date:  1998-01       Impact factor: 2.502

View more
  3 in total

1.  Effect of a Machine Learning-Derived Early Warning System for Intraoperative Hypotension vs Standard Care on Depth and Duration of Intraoperative Hypotension During Elective Noncardiac Surgery: The HYPE Randomized Clinical Trial.

Authors:  Marije Wijnberge; Bart F Geerts; Liselotte Hol; Nikki Lemmers; Marijn P Mulder; Patrick Berge; Jimmy Schenk; Lotte E Terwindt; Markus W Hollmann; Alexander P Vlaar; Denise P Veelo
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 2.  What is new in hemodynamic monitoring and management?

Authors:  Moritz Flick; Alina Bergholz; Pawel Sierzputowski; Simon T Vistisen; Bernd Saugel
Journal:  J Clin Monit Comput       Date:  2022-04-08       Impact factor: 1.977

3.  Narcotrend-guided intraoperative care of a Trisomy 21 paediatric patient who underwent occipitocervical fusion.

Authors:  Evangeline Ko Villa; Dominic Villa; Rafael C Bundoc
Journal:  BMJ Case Rep       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.